Dr. Reddy's Laboratories Reflects Broader Pharmaceutical Sector Trends Amidst Performance Challenges
Dr. Reddy's Laboratories has experienced notable trading activity, currently priced at Rs 1,175. The company, with a market cap of Rs 98,169.50 crore, has a P/E ratio significantly below the industry average. Over the past year, the stock has declined, contrasting with broader market trends.
Dr. Reddy's Laboratories, a prominent player in the Pharmaceuticals & Drugs sector, has shown notable activity today, underperforming the sector by 0.65%. The stock opened at Rs 1,175 and has maintained this price throughout the trading session. Currently, it is positioned above its 20-day and 50-day moving averages, yet below its 5-day, 100-day, and 200-day moving averages.With a market capitalization of Rs 98,169.50 crore, Dr. Reddy's Laboratories has a price-to-earnings (P/E) ratio of 18.38, significantly lower than the industry average of 35.69. Over the past year, the stock has declined by 6.46%, contrasting sharply with the Sensex's performance of 8.14%. In terms of shorter-term performance, the stock has seen a slight increase of 0.46% over the past week, but it remains down 15.26% year-to-date compared to the Sensex's gain of 3.26%.
As the pharmaceutical sector continues to evolve, Dr. Reddy's Laboratories remains a key player, reflecting the broader trends and challenges within the industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
